-transparent.png){kind=logo}
The comparison of drug product selection rates determined approximately one year and four years after passage of Florida's Drug Product Selection (DPS) Law indicates very little change in the product selection and brand interchange behaviors of Florida pharmacists. Lack of adequate guidelines from the state and the liability concerns of pharmacists appeared to limit an expected increase in the state DPS rate.
Related Publications
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
May 1980,
American journal of public health,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
September 1979,
American pharmacy,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
January 1980,
Contemporary pharmacy practice,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
January 1978,
Contemporary pharmacy practice,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
August 1982,
Medical care,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
May 1977,
American journal of hospital pharmacy,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
May 1980,
American journal of public health,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
October 1980,
American pharmacy,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
January 1979,
Contemporary pharmacy practice,
E H Clouse, and
W C McCormick, and
R A Angorn, and
C L Kimberlin, and
D D Bradham
January 2001,
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996),
